ASH Clinical News ACN_4.13_full issue_Web | Page 17

We’re excited to bring our
EXPLORER’S
EXPLORER
S SPIRIT
TO THE CHALLENGES OF
MYELOFIBROSIS
At Celgene, we’re working to develop therapies for patients with limited treatment options in areas of high
unmet medical need. With our focus on myelofibrosis, we’re building on our unwavering commitment to
hematologic malignancies and to improving the lives of patients worldwide.
© 2018 Celgene Corporation 08/18 US-CLG-18-0224